Muscle loss is a big concern for people on anti-obesity medications such as semaglutide. These ‘GLP-1 agonists’ mimic a ...

Researchers at Columbia University Irving Medical Center have identified the specific neurons in mice brains that tell them ...

Scientists mapped fat tissue differences in obese individuals, uncovering cell changes linked to metabolic disease risk and ...

Sharing her experience with GLP-1 weight loss drugs, Oprah reveals on the podcast, "One of the things that I realised the very first time I took a GLP-1 was that all these years, I thought that ...

Scientists found brainstem neurons that tell mice when to stop eating, offering insights for obesity treatments. Columbia ...

That means muscular people, including athletes, can have high BMI and could be considered on paper to have obesity when in reality they do not have too much body fat, also known as adiposity.

Obesity is estimated to affect more than one billion people worldwide. In the US, about 40 percent of adults have obesity, according to the US Centers for Disease Control and Prevention.

This can result in misdiagnosis, with negative consequences for people living with obesity. A secondary analysis of trends of prevalence, patterns, and predictors from 2005 to 2020 using the ...

The study, published Wednesday by JAMA Psychiatry, looked into 48 people the medical journal ... have also been known to help tackle obesity. Last year, another study published in JAMA Psychiatry ...

Intermittent Fasting Is Effective for Weight Loss and Improves Cardiovascular Health in People With Obesity Problems Jan. 8, 2025 — Scientists have conducted a pioneering study on the benefits ...

The trial investigated the safety, tolerability, pharmacokinetics, and proof-of-concept after once-weekly subcutaneous administrations of amycretin in 125 people with overweight or obesity.